CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Sokolove Jeremy Brett Chief Medical Officer | Shares withheld for taxes | −1,917 | $19.25 | $37K | 25,983 |
| 2026-10-02 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise | +500 | $12.80 | $6K | 500 |
| 2026-10-02 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise · Stock Option (Right to Buy) | −500 | 0 | ||
| 2026-08-24 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise | +1,500 | $3.74 | $6K | 1,500 |
| 2026-08-24 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise · Stock Option (Right to Buy) | −1,500 | 0 | ||
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise | +2,100,000 | $0.00 | $4K | 4,502,095 |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Sale | −213 | $19.75 | $4K | 4,501,882 |
| 2026-07-16 | RA CAPITAL MANAGEMENT, L.P. 10% owner | Option exercise · Pre-Funded Warrant (Right to Buy) | −2,100,000 | $5.00 | $10.5M | 7,900,000 |
| 2026-07-07 | ZACCARDELLI DAVID Director | Grant or award · Stock Option (Right to Buy) | +42,658 | 42,658 | ||
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +57,162 | 57,162 | ||
| 2026-06-11 | Detheux Michel Director | Grant or award · Stock option (right to buy) | +57,162 | 57,162 | ||
| 2026-06-11 | Namouni Fouad Director | Grant or award · Stock Option (right to buy) | +56,549 | 56,549 | ||
| 2026-06-11 | Joustra Wouter Director | Grant or award · Stock option (right to buy) | +57,162 | 57,162 | ||
| 2026-06-11 | Kalir Erez Director | Grant or award · Stock Option (right to buy) | +57,162 | 57,162 | ||
| 2026-06-11 | Cumbo Alexander Director | Grant or award · Stock option (right to buy) | +56,345 | 56,345 | ||
| 2026-06-11 | Beckman Daniella Director | Grant or award · Stock option (right to buy) | +53,283 | 53,283 | ||
| 2026-06-11 | Levin Andrew David Director | Grant or award · Stock option (right to buy) | +57,162 | 57,162 | ||
| 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −165,150 | $15.77 | $2.6M | 2,402,095 |
| 2026-04-20 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −171,963 | $15.77 | $2.7M | 2,567,245 |
| 2026-04-17 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −458,411 | $16.28 | $7.5M | 2,739,208 |
Page 1 of 18 · 344 trades